Login / Signup

Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.

Ricardo Peña-SilvaStephen B DuffullAndrew C SteerSandra X Jaramillo-RinconAmanda GweeXiao Zhu
Published in: British journal of clinical pharmacology (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • combination therapy